Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

Summary by The Toronto Star
NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that its wholly-owned Texas subsidiary, Texas Ibogaine Research Corporation (“TIRC”), has entered into a binding term sheet with Psyence Labs…

8 Articles

The Toronto StarThe Toronto Star
+6 Reposted by 6 other sources
Lean Left

Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation

NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that its wholly-owned Texas subsidiary, Texas Ibogaine Research Corporation (“TIRC”), has entered into a binding term sheet with Psyence Labs…

·Toronto, Canada
Read Full Article
Mugglehead MagazineMugglehead Magazine

Psyence Biomedical Ltd. enters U.S. ibogaine terms

Its Texas subsidiary would pay PsyLabs the milestones for the first drug candidate; the binding terms lapse without a definitive agreement by Nov. 30.

·Vancouver, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources lean Left
57% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Record broke the news in Woodland Park, United States on Monday, September 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Texas, United States icon

Texas, United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal